Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment.

Abstract

Psoriasis is a chronic inflammatory systemic disease primarily affecting the skin, but which often involves considerable comorbidities as well. One-third of psoriasis cases start during childhood. In pediatric psoriasis, an association with several medical comorbidities is also indicated. Furthermore, because of its chronic nature and frequent relapses, psoriatic patients tend to require long-term treatment and experience negative impacts on their quality of life. Considering the different clinical characteristics of pediatric psoriasis, it has recently been presented that the pathogenesis of pediatric psoriasis is distinct from adult psoriasis. Treatment for pediatric psoriasis usually involves the same methods as for adults. However, most treatments in pediatric psoriasis are used off-label and research in this regard is still lacking. Targeted therapies involving newly developed biologics are also increasingly being applied to psoriasis in children. This review summarizes the clinical characteristics of pediatric psoriasis and focuses mainly on the updated concepts of pathogenesis and treatments in pediatric psoriasis. This was undertaken to widen the understanding of these relevant aspects and to provide better management of pediatric psoriasis by clinicians.

• Authors: Hye One Kim, Seok Young Kang, Jin Cheol Kim, Chun Wook Park, Bo Young Chung
• Journal: Biomedicines (Biomedicines) Vol. 9 Issue 8 (Aug 02 2021) ISSN: 2227-9059 [Print] Switzerland
• PMID: 34440145 (Publication Type: Journal Article, Review)